Patent ID: 9382265
Filing Date: 2016-07-05
CPC Classification: A61P,C07D

Claim Text:
1. An oxazolidone compound represented by the following formula (I), an enantiomer, diastereoisomer and racemate thereof as well as their mixtures, and a pharmaceutically acceptable salt thereof; wherein, R R in said substituted or unsubstituted —(CH in the circumstance of substituted —(CH in the circumstance of substituted phenyl, the substituent of phenyl is a radical selected from the group consisting of: halogen, —NO said 5- or 6-membered heterocyclic group or benzo 5- or 6-membered heterocyclic group contains at least one heteroatom selected from N, O or S; in the circumstance of substituted 5- or 6-membered heterocyclic group or substituted benzo 5- or 6-membered heterocyclic group, the substituent of 5- or 6-membered heterocyclic group or benzo 5- or 6-membered heterocyclic group is a radical selected from the group consisting of: halogen, —NO R in the circumstance of substituted C in the circumstance of substituted phenyl, the substituent of phenyl is a radical selected from the group consisting of: F, Cl, Br, CN, —NO said 5- or 6-membered aromatic heterocyclic group contains at least one heteroatom selected from N, O or S, and in the circumstance of substituted 5- or 6-membered aromatic heterocyclic group, the substituent of 5- or 6-membered aromatic heterocyclic group is a radical selected from the group consisting of: F, Cl, Br, CN, —NO said 5- or 6-membered non-aromatic heterocyclic group contains at least one heteroatom selected from N, O or S, and said heterocyclic group can further form a spiroring with another 3 to 6-membered heterocyclic group; and in the circumstance of substituted 5- or 6-membered non-aromatic heterocyclic group, the substituent of 5- or 6-membered non-aromatic heterocyclic group is a radical selected from the group consisting of: oxo, F, Cl, Br, C